# Patient-derived Tumor-like Cell Cluster Model-based Precision Treatment Strategy on Non-small Cell Lung Cancer

> **NCT07328945** · — · RECRUITING · sponsor: **Shanghai Pulmonary Hospital, Shanghai, China** · enrollment: 250 (estimated)

## Conditions studied

- Non-small Cell Lung Cancer

## Interventions

- **DIAGNOSTIC_TEST:** PTC predicts the response to drug therapy in lung cancer patients

## Key facts

- **NCT ID:** NCT07328945
- **Lead sponsor:** Shanghai Pulmonary Hospital, Shanghai, China
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2023-12-01
- **Primary completion:** 2027-01
- **Final completion:** 2028-07
- **Target enrollment:** 250 (ESTIMATED)
- **Last updated:** 2026-01-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07328945

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07328945, "Patient-derived Tumor-like Cell Cluster Model-based Precision Treatment Strategy on Non-small Cell Lung Cancer". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07328945. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*